Clinical and immunological evaluation after BCG-id vaccine in leprosy patients in a 5-year follow-up study

Journal of Inflammation Research

Volumn 5, Issue 1, 2012, Pages 125-135

  Zenha, Erika Muller Ramalho ^a   Wambier, Carlos Gustavo ^a   Novelino, Ana Lúcia ^a   de Andrade, Thiago Antônio Moretti ^a   Ferreira, Maria Aparecida Nunes ^a   Frade, Marco Andrey Cipriani ^a   Foss, Norma Tiraboschi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

BCG; Immunology; Leprosy

Indexed keywords

BCG VACCINE; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BCG VACCINATION; CELL ISOLATION; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MALE; MULTIBACILLARY LEPROSY; PAUCIBACILLARY LEPROSY; PERIPHERAL BLOOD MONONUCLEAR CELL; SCHOOL CHILD; SKIN BIOPSY; TREATMENT OUTCOME; TUBERCULOID LEPROSY;

EID: 84871639439     PISSN: None     EISSN: 11787031     Source Type: Journal    
DOI: 10.2147/JIR.S33854     Document Type: Article

References (36)

1. World Health Organization. Leprosy update, 2011. Wkly Epidemiol Rec. 2011;86(36):389-400.
2. Ministério da Saúde. Coordenação Geral do Programa Nacional de Controle da Hanseníase-CGPNCH [Hansen's Disease Control National Program]. Brasília: Ministério da Saúde; 2011. Available from: http://www.google.ca/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CCMQFjAA&url=http%3A%2F%2Fwww.ilep.org.uk%2Ffileadmin%2Fuploads%2FCountry_Pages%2FBrazil%2FReport_NHDCP_2011_web.pdf&ei=AEl6UKO0E6azyQG8iYDQAg&usg=AFQjCNEbaMFiccRpuCOrBiBcuhHs8D1iMg&sig2=de23c3KFH09VSRJ6R2a7pg&cad=rja. Accessed October 12, 2012. Portuguese.
3. Fernandez JM. The early reaction induced by lepromin. Int J Lepr Other Mycobact Dis. 1940;8:1-14.
4. Stanley SJ, Howland C, Stone MM, Sutherland I. BCG vaccination of children against leprosy in Uganda: final results. J Hyg (Lond). 1981;87(2):233-248.
5. Gupte MD. Field trials of antileprosy vaccines. Indian J Lepr. 1998;70(4):363-367.
6. Lwin K, Sudaresan T, Gyi MM, et al. BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. Bull World Health Organ. 1985;63(6):1069-1078.
7. Bagshawe A, Scott GC, Russel DA, Wingley SC, Merianos A, Berry G. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-1979. Bull World Health Organ. 1989;67(4):389-399.
8. Zodpey SP. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis. Indian J Dermatol Venereol Leprol. 2007;73(2):86-93.
9. Narang T, Kaur I, Kumar B, Radotra BD, Dogra S. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Int J Lepr Other Mycobact Dis. 2005;73(2):105-114.
10. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34(3):255-273.
11. Ridley DS. Therapeutic trials in leprosy using serial biopsies. Lepr Rev. 1958;29(1):45-52.
12. Zenha EM, Ferreira MA, Foss NT. Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients. Braz J Med Biol Res. 2009;42(10):968-972.
13. Ministério da Saúde, Secretaria de Políticas de Saúde, Departamento de Atenção Básica. Controle da Hanseníase Na Atenção Básica: Guia Prático Para Profissionais da Equipe de Saúde Da Família [Leprosy Control in Primary Care: A Practical Guide for Professionals in Family Health Team]. Brasília: Ministério da Saúde; 2001. Portuguese.
14. Foss MC, Foss NT, Paccola GM, Silva CL. Serum levels of tumor necrosis factor in insulin-dependent diabetic patients. Braz J Med Biol Res. 1992;25(3):239-242.
15. Bonato VLD. Correlação dos Anticorpos Anti-PGL-I com o Índice Baciloscópico, a Reação De Mitsuda, o Tratamento Poliquimioterápico e as Interleucinas nas Diferentes Formas da Hanseníase [Correlation of Antibodies Ant-PGL-1 with Bacterial Index, the Mitsuda Reaction from Chemotherapy Treatment and Interleukins in Different Forms of Leprosy] [Master's thesis]. São Paulo: Universidade de São Paulo; 1995. Portuguese.
16. Chen ZL, Tang QG, Wang ZM, Chen J. Pilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML+ BCG) vaccine to induce skin test conversion. Lepr Rev. 1993;64(2):117-127.
17. Beck-Bleumink M, Berhe D. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr Other Mycobact Dis. 1992;60(2):173-184.
18. Zaheer AS, Misra RS, Sharma AK, et al. Immunotherapy with Mycobacteruim w vaccine decreases the incidence and severity of type 2 (ENL) reactions. Lepr Rev. 1993;64(1):7-14.
19. Sharma P, Kar HK, Misra RS, et al. Reactional states and neuritis in multibacillary leprosy patients following MDT with/without immunotherapy with Mycobacterium w antileprosy vaccine. Lepr Rev. 2000;71(2):193-205.
20. Moura RS, Calado KL, Oliveira ML, Bührer-Sékula S. Leprosy serology using PGL-1: a systematic review. Rev Soc Bras Med Trop. 2008;41 Suppl 2:S11-S18.
21. Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol. 1999;163(4):2249-2255.
22. Murray HW, Rubin BY, Rothermel CD. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest. 1983;72(4):1506-1510.
23. Sieling PA, Modlin RL. Cytokine patterns at the site of mycobacterial infection. Immunobiology. 1994;191(4-5):378-387.
24. Mills KH, McGuirk P. Antigen-specific regulatory T cells-their induction and role in infection. Semin Immunol. 2004;16(2):107-117.
25. Apte RS. Regulation of angiogenesis by macrophages. Adv Exp Med Biol. 2010;664:15-19.
26. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RH. Macrophages in skin injury and repair. Immunobiology. 2011;216(7):753-762.
27. Gopal R, Lin Y, Obermajer N, et al. IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination. Eur J Immunol. 2012;42(2):364-373.
28. Umemura M, Yahagi A, Hamada S, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guérin infection. J Immunol. 2007;178(6):3786-3796.
29. Li L, Huang L, Vergis AL, et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest. 2010;120(1):331-342.
30. Conti-Freitas LC, Foss-Freitas MC, Mamede RC, Foss NT. Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer. Cancer Immunol Immunother. 2009;58(1):25-29.
31. Silva CL, Foss NT. Tumor necrosis factor in leprosy patients. J Infect Dis. 1989;159(4):787-790.
32. Castilho MLOR. Correlação Entre BCG Intradérmico e Linfoproliferação, Produção e Expressão de Rnam das Citocinas Ifng, IL-12, IL-10 E IL-4, Níveis de Anti-PGL-1 em Pacientes com Hanseníase e em Seus Comunicantes [Correlation Between BCG and Lymphoproliferation, Production and mRNA Expression of Cytokines IFNg, IL-12, IL-10 and IL-4, Levels of Anti-PGL-1in Leprosy Patients and their Contacts] [Master's thesis]. São Paulo: Universidade de São Paulo; 2001. Portuguese.
33. Sengupta U. Cell-mediated immunity in leprosy: an update. Int J Lepr Other Mycobact Dis. 1993;61(3):439-454.
34. Rada E, Santaella C, Aranzazu N, Convit J. Preliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patients. Int J Lepr Other Mycobact Dis. 1992;60(2):189-194.
35. Rada E, Ulrich M, Aranzazu N, et al. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Int J Lepr Other Mycobact Dis. 1994;62(4):552-558.
36. Rada E, Ulrich M, Aranzazu N, et al. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT+ immunotherapy (IMT). Int J Lepr Other Mycobact Dis. 1997;65(3):320-327.